Navigation Links
Congressional Budget Includes Earmark to Keep Washington's Sexual Assault DNA Program Moving Forward
Date:1/10/2008

Funding will allow the Washington Association of Sheriffs and Police Chiefs

to quickly identify rapists through a 30-Day DNA testing program

OLYMPIA, Wash., Jan. 10 /PRNewswire/ -- The Omnibus Appropriations bill signed by the President on December 26, 2007 included a $961,000 earmark for the Washington Association of Sheriffs and Police Chiefs (WASPC) to continue the important DNA Stranger Rape Program.

"Without this funding, our DNA Stranger Rape Program would have ended in 2008. With these funds, we can quickly solve rape cases and prevent additional rapes by keeping sex predators off the streets," said Don Pierce, Executive Director of WASPC.

In November 2006, WASPC began the DNA Stranger Rape Program. The program utilizes a private laboratory to analyze DNA evidence from rape cases in 30 days or less. Prior to this program, when a stranger rape occurred, the rape kit was routinely placed into a long backlog of no suspect cases.

The WASPC DNA Stranger Rape Program is designed to be fast and effective. When a stranger rape occurs in Washington State, WASPC immediately works with the local law enforcement agency to ensure the rape kit is on a plane to a lab in Dallas, Texas. There, it receives priority DNA testing by a private DNA testing laboratory that is able to guarantee results within 30 days. The test results are then compared to known suspects and given to the Washington State Patrol to be compared to state and national DNA databases. National statistics indicate that a match with a suspect will occur in approximately one third of the cases where there was no original suspect.

The DNA Stranger Rape Program has been very effective and produced immediate results upon implementation. Within a week of starting the program, it identified the rapist of a young girl in Olympia in a highly publicized case. In addition to identifying the actual perpetrator, the DNA test exonerated an innocent suspect.

Knowing that the program was scheduled to run out of funding in 2008, WASPC approached the Washington Congressional delegation for help. Through the collective efforts of Senators Murray and Cantwell and Congressmen Dicks, Smith, and Reichert, the funding was secured. "The delegation got behind this project," said Pierce. "We are fortunate in Washington State to have a group of congressional members who are able to secure funds for important Washington State programs."

With the $961,000 congressional earmark, the program will likely have sufficient funding to operate through 2009.

For more information on WASPC and the DNA Stranger Rape Program visit http://www.waspc.org.


'/>"/>
SOURCE Don Pierce
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement by American Heart Association Immediate-Past President Raymond Gibbons, M.D. on Congressional Omnibus Spending Bill
2. NCPA Applauds Pharmacy TRICARE Provisions in the Congressional Passage of the Defense Authorization Bill
3. Lung Cancer Alliance Praises Congressional Call for Increased Commitment to Fund Lung Cancer Research
4. National physician organization supports Capps-Rogers Bill at todays congressional briefing
5. Congressional failure to override SCHIP veto saddens physicians
6. American Heart Association Congratulates Pioneer Heart Surgeon for Being Named Recipient of Congressional Gold Medal Award
7. Capps to Lead Bipartisan Womens Caucus Congressional Delegation to Represent United States at Women Deliver Conference in London
8. Congressional Support Grows for FDA Regulation of Tobacco: Bill Now Sponsored by 55 Senators, 200 Representatives
9. AGD Applauds Congressional Support of SCHIP Reauthorization
10. More than 125 State Leaders - Including Governor, Lt. Governor, and Congressional Delegation - Endorse Campaign to Make Delawares Kids the Healthiest in the Nation
11. Congressional and Religious Leaders to Urge Over-ride of Presidential SCHIP Veto
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Georgia (PRWEB) , ... March 27, 2017 , ... ... to announce that for a second year in a row; they are the ... healthcare designers in the industry voted on the award at Design Connections 2017. ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium ... methods are complicated and require expert user knowledge. In a live webinar on ... to the simplified, yet highly accurate, determination of sodium. , It has long ...
(Date:3/27/2017)... Clearwater, Fla. (PRWEB) , ... March 27, 2017 , ... ... (1) and the number of homeowners utilizing DIY and unlicensed contractors for renovations is ... bathroom remodel or replacement project in 2015, and of those, 42% failed to use ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... soil, dredged material, and hazardous and non-hazardous materials announced today the acquisition of ... This acquisition will add four additional processing facilities and a vast array of ...
(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business Management Association (RBMA) ... awards, now in their 12th year, are among the most prestigious in radiology marketing ... the awards were retooled to recognize achievements in both large budget (over $5,000) and ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017 On Friday, ... NASDAQ Composite closed the trading session up 0.19%; the ... S&P 500 was down 0.08%. US markets made broad ... the day in green. Pre-market today, Stock-Callers.com reviews these ... N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group ...
(Date:3/27/2017)... March 27, 2017  Twist Bioscience, a company accelerating ... announced that it raised an additional $33 million. To ... million. "It is an exciting time ... reach and continue to deliver industry-leading gene volume to ... commented Emily M. Leproust, Ph.D., CEO of Twist Bioscience. ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. ... for life-threatening inherited liver diseases in children, today ... full year ended December 31, 2016 and provided ... "PhaseRx continued to make progress during the ... positive results from our non-human primate safety study, and ...
Breaking Medicine Technology: